CXCL8 and osteosarcoma: Large-scale purification of natural CXCL8 from diverse cellular sources including osteosarcoma cells (MG-63), fibroblasts, monocytes, endothelial and epithelial cells, revealed NH2-terminal sequence heterogeneity (15, 19, 30–34).